|
David Poorvin, PhD became a director in May of 2006. Dr Poorvin has been a consultant for Poorvin Enterprises and served as Executive-in-Residence for Oxford Biosciences Partners. Dr. Poorvin is a director of Enanta Pharmaceuticals and Repros Therapeutics Inc. Dr. Poorvin held numerous senior management positions with the Schering-Plough Corporation, a global research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical biotechnology products and health care products, including Vice President of Business Development Operations and Director of Cardiovascular Clinical Research. Dr. Poorvin holds a BA from Hunter College of the City University of New York, and PhD from Rutgers University. | 